Marcus Boehm - 30 Mar 2022 Form 4 Insider Report for Vyant Bio, Inc.

Role
Director
Signature
/s/ Andrew LaFrence, attorney-in-fact
Issuer symbol
N/A
Transactions as of
30 Mar 2022
Net transactions value
$0
Form type
4
Filing time
01 Apr 2022, 16:30:27 UTC
Previous filing
20 Jan 2022
Next filing
19 Apr 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VYNT Common Stock, $0.0001 par value Award +43,478 +759% 49,203 30 Mar 2022 Direct F1
holding VYNT Common Stock, $0.0001 par value 128,786 30 Mar 2022 By Trust
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 30, 2022, the Reporting Person was granted 43,478 restricted stock units, which will be settled in shares of common stock, par value $0.0001. The restricted stock units fully vest on March 30, 2023, so long as Reporting Person remains a director though that date.